CLDX
Celldex Therapeutics Inc
31.50$
+1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 87.8% | 92.7% | 96.1% | 96.0% | 94.6% | 94.3% | 93.8% | 93.6% | 93.2% | 91.7% | 89.8% | 92.7% | |
| 7.5% | 7.5% | 13.2% | 5.1% | 4.4% | 3.6% | 2.3% | 3.3% | 5.6% | 5.0% | 7.0% | 6.1% | |
| 84.0% | 90.6% | 94.8% | 94.9% | 91.8% | 91.5% | 91.1% | 91.0% | 89.9% | 89.0% | 88.3% | 91.7% | |
| 0.1% | 1.0% | 0.3% | 0.2% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.3% | 0.0% | 0.0% | |
| 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| 9.7% | 5.8% | 3.1% | 3.2% | 3.3% | 3.4% | 3.7% | 3.9% | 4.2% | 4.7% | 5.3% | 3.5% | |
| 12.0% | 7.8% | 3.5% | 3.8% | 4.5% | 5.7% | 4.9% | 5.3% | 7.7% | 9.6% | 10.8% | 8.7% | |
| 9.9% | 6.7% | 3.0% | 3.3% | 3.9% | 5.0% | 4.3% | 4.8% | 7.2% | 8.7% | 10.1% | 7.8% | |
| 0.6% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 0.3% | 0.2% | |
| 1.3% | 0.8% | 0.4% | 0.4% | 0.1% | 0.4% | 0.5% | 0.3% | 0.7% | 0.2% | 2.0% | 1.9% | |
| 88.0% | 92.2% | 96.5% | 96.2% | 95.5% | 94.3% | 95.1% | 94.7% | 92.3% | 90.4% | 89.2% | 91.3% | |
| -483.1% | -300.1% | -164.6% | -173.4% | -183.2% | -196.3% | -217.6% | -240.6% | -267.2% | -311.2% | -370.2% | -251.3% | |
| 16.9% | 11.2% | 6.8% | 7.8% | 8.1% | 8.4% | 9.0% | 9.6% | 10.2% | 11.4% | 13.0% | 9.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.